CA2409705A1 - Gene responsible for stargardt-like dominant macular dystrophy - Google Patents

Gene responsible for stargardt-like dominant macular dystrophy Download PDF

Info

Publication number
CA2409705A1
CA2409705A1 CA002409705A CA2409705A CA2409705A1 CA 2409705 A1 CA2409705 A1 CA 2409705A1 CA 002409705 A CA002409705 A CA 002409705A CA 2409705 A CA2409705 A CA 2409705A CA 2409705 A1 CA2409705 A1 CA 2409705A1
Authority
CA
Canada
Prior art keywords
elf
seq
protein
leu
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002409705A
Other languages
English (en)
French (fr)
Inventor
Konstantin Petrukhin
Wen Li
Kang Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Merck and Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2409705A1 publication Critical patent/CA2409705A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002409705A 2000-05-16 2001-05-11 Gene responsible for stargardt-like dominant macular dystrophy Abandoned CA2409705A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20499000P 2000-05-16 2000-05-16
US60/204,990 2000-05-16
PCT/US2001/015464 WO2001087921A2 (en) 2000-05-16 2001-05-11 Gene responsible for stargardt-like dominant macular dystrophy

Publications (1)

Publication Number Publication Date
CA2409705A1 true CA2409705A1 (en) 2001-11-22

Family

ID=22760322

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002409705A Abandoned CA2409705A1 (en) 2000-05-16 2001-05-11 Gene responsible for stargardt-like dominant macular dystrophy

Country Status (3)

Country Link
EP (1) EP1283897A4 (de)
CA (1) CA2409705A1 (de)
WO (1) WO2001087921A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297523B2 (en) 2000-11-29 2007-11-20 Xenon Pharmaceuticals Inc. Human elongase genes and uses thereof
WO2010011944A2 (en) 2008-07-25 2010-01-28 Wagner Richard W Protein screeing methods
WO2013166037A1 (en) 2012-05-01 2013-11-07 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of eye disorders
WO2014152013A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York 4-phenylpiperidines, their preparation and use
US9938291B2 (en) 2013-03-14 2018-04-10 The Trustess Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
ES2700541T3 (es) 2013-03-14 2019-02-18 Univ Columbia Octahidrociclopentapirroles, su preparación y uso
WO2014151936A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles, their preparation and use
DK4036094T3 (da) 2014-04-30 2026-03-23 Univ Columbia Erstattede 4-fenylpiperidiner, deres fremstilling og anvendelse

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5394100A (en) * 1999-05-20 2000-12-12 Karolinska Innovations Ab Fatty acid elongation genes and uses thereof

Also Published As

Publication number Publication date
WO2001087921A2 (en) 2001-11-22
EP1283897A4 (de) 2004-08-04
EP1283897A2 (de) 2003-02-19
WO2001087921A3 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
JP7292836B6 (ja) Ｍｅｃｐ２ｅ１遺伝子
US20160215347A1 (en) LaFORA'S DISEASE GENE
US7179620B2 (en) Gene responsible for stargardt-like dominant macular dystrophy
CA2311414A1 (en) Diagnostic method, diagnostic reagent and therapeutic preparation for diseases caused by variation in lkb1 gene
EP0815197B1 (de) "long qt" gene und methode zur diagnose oder prävention des "long qt" syndroms
WO2001087921A2 (en) Gene responsible for stargardt-like dominant macular dystrophy
WO1996028537A9 (en) Long qt genes and method for diagnosing or preventing the occurrence of long qt syndrome
JP4062638B2 (ja) フラビンモノオキシゲナーゼをコードするヌクレオチド配列、これに相当するタンパク質ならびに診断および治療領域におけるそれらの使用
CA2281887C (en) Nucleic acid sequences for atp-binding cassette transporter
JP2004500077A (ja) ステロイド抵抗性ネフローゼ症候群に関与するｎｐｈｓ２遺伝子、上記遺伝子によりコードされるタンパク質、並びにそれらの診断的及び治療的使用
JPH11509730A (ja) 早発性アルツハイマー病遺伝子および遺伝子産物
JP4324472B2 (ja) アトラスチン
US20040267000A1 (en) Atherosclerosis susceptibility gene locus 1(athsq1) and atherosclerosis susceptibility gene locus 2 (athsq2)
CA2373466C (en) Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (eaoh)
US7141381B2 (en) Human leucine-rich repeat-containing proteins specifically expressed in the nervous system
US7005290B1 (en) Best's macular dystrophy gene
US20040137450A1 (en) Als2 gene and amyotrophic lateral sclerosis type 2
WO2002072822A2 (en) Als2 gene and amyotrophic lateral sclerosis type 2
WO2002027022A2 (en) Methods for diagnosing and treating autosomal dominant optic atrophy
US20040126858A1 (en) Novel polypeptide-nadp dependent leukotriene b412-hydroxydehydrogenase-36 and the polynucleotide encoding said polypeptide
WO2000018787A1 (en) Gene mutated in wolfram syndrome
KR100508845B1 (ko) KVLQT1을 코딩하는 장기 QT증후군 유전자 및 KVLQT1과 minK의 결합체
WO1999063078A2 (en) Retinal calcium channel (alpha)1f-subunit gene
CA2306241A1 (en) Retinal gpi-anchored small leucine-rich of proteoglycan gene
Meitinger et al. The Norrie Disease Gene: Positional Cloning, Mutation Analysis and Protein Homologies

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead